Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Zamicastat | C21H21F2N3OS | 1080028-80-3 | Details |
| Z433927330 | C20H20N4O3 | 1005883-72-6 | Details |
| Sucralfate | C11H52Al16O75S8-16 | 54182-58-0 | Details |
| Zaltidine；CP-57361 | C8H10N6S | 85604-00-8 | Details |
| (Z)-Pitavastatin calcium | C25H26CaFNO4 | 1159588-21-2 | Details |
| Y-33075；Y 39983 | C16H16N4O | 199433-58-4 | Details |
| YS-49 | C20H20BrNO2 | 132836-42-1 | Details |
| Z-Asp-CH2-DCB | C20H17Cl2NO7 | 153088-73-4 | Details |
| YM758 | C26H32FN3O4 | 312752-85-5 | Details |
| (Z)-Leukadherin-1；ADH-503 free base | C22H15NO4S2 | 2055362-72-4 | Details |
| (Z)-10-Hydroxynortriptyline；(Z)-10-Hydroxy Nortriptyline | C19H21NO | 47132-19-4 | Details |
| YHO-13351 free base | C26H33N3O4S | 912288-64-3 | Details |
| YHO-13351 | C27H37N3O7S2 | 1346753-00-1 | Details |
| YLF-466D | C29H20ClNO3 | 1273323-67-3 | Details |
| Pamidronate Disodium | C3H12NNaO7P2 | 57248-88-1 | Details |
| YM17E | C40H56N6O2 | 124900-72-7 | Details |
| Y06137 | C27H32N4O2 | 2226534-49-0 | Details |
| YAP/TAZ inhibitor-1 | C33H39N3O5S2 | 2093565-23-0 | Details |
| YM-264 | C24H32N4OS.C4H4O4 | 131888-54-5 | Details |
| YM-53601 free base | C21H21FN2O | 182959-28-0 | Details |
| YM-58790 | C27H32ClN3O2 | 214558-72-2 | Details |
| YM-46303 | C20H23ClN2O2 | 171722-81-9 | Details |
| VTP50469 fumarate | C36H51FN6O8S | 2169919-29-1 | Details |
| VTP50469 | C32H47FN6O4S | 2169916-18-9 | Details |
| WEHI-345 analog | C23H25N7O | 1354825-62-9 | Details |
| Wf-516 | C25H25Cl2N3O4 | 310392-94-0 | Details |
| Hydroquinidine；Dihydroquinidine;Hydroconquinine;(+)-Hydroquinidine;Dihydroquinine;Hydroconchinine | C20H26N2O2 | 1435-55-8 | Details |
| WEHI-539 hydrochloride | C31H30ClN5O3S2 | 2070018-33-4 | Details |
| XY101 | C25H20F7NO4S | 2349368-16-5 | Details |
| Wnt pathway activator 2 | C17H15NO4 | 1360540-82-4 | Details |
| Wnt/β-catenin agonist 1 | C22H25N3O2 | 2305372-67-0 | Details |
| WY-135 | C28H34ClN9O3S | 2163060-83-9 | Details |
| XL-784 | C21H22ClF2N3O8S | 1224964-36-6 | Details |
| XY028-133 | C53H67N11O7S | 2229974-73-4 | Details |
| XPC-6444 | C22H25F3N4O2S2 | 2230144-21-3 | Details |
| XL-784 free base | C21H22ClF2N3O8S | 1356992-21-6 | Details |
| Xanthoangelol | C25H28O4 | 62949-76-2 | Details |
| Mycophenolic acid | C17H20O6 | 24280-93-1 | Details |
| Wy 49051 | C28H33N5O3 | 113418-56-7 | Details |
| 20-HEDE；WIT 002 | C20H36O3 | 240427-90-1 | Details |
| WDR5-IN-4；WIN site inhibitor 1 | C25H22Cl2FN5O | 2407457-36-5 | Details |
| Win 58237 | C16H17N5O | 158001-76-4 | Details |
| Win-62005 | C12H10N4O | 152633-54-0 | Details |
| WS-383 free base | C18H20ClN9S2 | 2247543-65-1 | Details |
| WQ 2743 | C19H15BrF3N5O3 | 189280-13-5 | Details |
| WQ3810；KPI-10 free base | C22H22F3N5O3 | 888032-58-4 | Details |
| WS-383 | C18H21Cl2N9S2 | 2247544-02-9 | Details |
| Wushanicaritin | C21H22O7 | 521-45-9 | Details |
| Xanomeline oxalate | C14H23N3OS.C2H2O4 | 141064-23-5 | Details |
| Benztropine mesylate | C22H29NO4S | 132-17-2 | Details |
| XEN723 | C21H20FN5O2S | 1072803-08-7 | Details |
| Xanthorrhizol | C15H22O | 30199-26-9 | Details |
| VD2-D3 | C28H44O | 1217448-46-8 | Details |
| Veledimex racemate；INXN-1001 racemate;RG-115932 racemate | C27H38N2O3 | 755013-59-3 | Details |
| Viquidil hydrochloride | C20H25ClN2O2 | 52211-63-9 | Details |
| Acitretin | C21H26O3 | 55079-83-9 | Details |
| Verubulin hydrochloride | C17H17N3O.HCl | 917369-31-4 | Details |
| VD3-D6；Vitamin D3-26,26,26,27,27,27-d6 | C27H38D6O | 118584-54-6 | Details |
| Violanthin | C27H30O14 | 40581-17-7 | Details |
| Vicenin 3 | C26H28O14 | 59914-91-9 | Details |
| Veledimex (S enantiomer)；RG-115932 S enantiome;INXN-1001 S enantiome | C27H38N2O3 | 1093131-03-3 | Details |
| Veliflapon；BAY X 1005;DG-031 | C23H23NO3 | 128253-31-6 | Details |
| Verminoside | C24H28O13 | 50932-19-9 | Details |
| Verruculogen | C27H33N3O7 | 12771-72-1 | Details |
| Vilazodone-d8；Vilazodone D8 | C26H26N5O2 | 1794789-93-7 | Details |
| EHP-101 | C28H35NO3 | 1818428-24-8 | Details |
| Vofopitant dihydrochloride | C21H23F3N6O2HCl | 168266-51-1 | Details |
| Tolazamide | C14H21N3O3S | 1156-19-0 | Details |
| WAY127093B racemate | C23H28N4O4 | 145743-63-1 | Details |
| WDR5-IN-1 | C30H31FN4O3 | 2408842-51-1 | Details |
| (Rac)-WAY-161503 | C11H11Cl2N3O | 75704-24-4 | Details |
| WD2000-012547 | C17H14N2O | 283172-68-9 | Details |
| VTX-27 | C20H24ClFN6O | 1321924-70-2 | Details |
| VU0134992 hydrochloride | C20H32BrClN2O2 | 1052515-91-9 | Details |
| Seviteronel R enantiomer | C18H17F4N3O3 | 1375603-38-5 | Details |
| VUF11207 fumarate | C31H39FN2O8 | 1785665-61-3 | Details |
| VU 0365114 | C22H14F3NO3 | 1208222-39-2 | Details |
| W146 | C16H27N2O4P | 909725-61-7 | Details |
| Vofopitant | C21H23F3N6O | 168266-90-8 | Details |
| AE0047 Hydrochloride | C41H43ClN4O6 | 116308-56-6 | Details |
| VU6005806；AZN-00016130 | C17H16F3N7O2S | 2180914-37-6 | Details |
| SPR719；VXc-486 | C21H25FN6O3 | 1384984-18-2 | Details |
| Riboflavin phosphate sodium | C17H22N4NaO9P | 130-40-5 | Details |
| Viridicatol | C15H11NO3 | 14484-44-7 | Details |
| Virginiamycin M1 | C28H35N3O7 | 21411-53-0 | Details |
| VP3.15 | C20H22N4OS | 1281681-54-6 | Details |
| Voruciclib hydrochloride | C22H20Cl2F3NO5 | 1000023-05-1 | Details |
| VU 6008667 | C24H17ClF2N2O2 | 2092923-21-0 | Details |
| Seviteronel racemate；VT-464 (racemate) | C18H17F4N3O3 | 1375603-36-3 | Details |
| Vps34-IN-2 | C18H25F3N4O3 | 1523404-29-6 | Details |
| Vortioxetine D8；Lu AA 21004 D8 | C18H22N2S | 2140316-62-5 | Details |
| VU591 hydrochloride | C16H13ClN6O5 | 1315380-70-1 | Details |
| VU0650786 | C18H15ClFN5O2 | 1809085-30-0 | Details |
| VU6005649 | C16H12F5N3O | 2137047-43-7 | Details |
| Permethrin | C21H20Cl2O3 | 52645-53-1 | Details |
| VU0364770 hydrochloride | C12H10Cl2N2O | 1414842-70-8 | Details |
| VU0652835 | C16H19N3O3S | 1848252-81-2 | Details |
| Virginiamycin S1 | C43H49N7O10 | 23152-29-6 | Details |
| Vapreotide；RC160;BMY 41606 | C57H70N12O9S2 | 103222-11-3 | Details |
| Vapreotide acetate；RC-160 acetate;BMY-41606 acetate | C59H74N12O11S2 | 849479-74-9 | Details |
| Product Total： Product Page： | ||||
| 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 | ||||